Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 102.00
Bid: 101.00
Ask: 103.00
Change: 0.00 (0.00%)
Spread: 2.00 (1.98%)
Open: 102.00
High: 102.00
Low: 102.00
Prev. Close: 102.00
CNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

26 Aug 2014 07:00

RNS Number : 8998P
Concurrent Technologies PLC
26 August 2014
 



26 August 2014

 

CONCURRENT TECHNOLOGIES PLC

Interim Results for the six months ended 30 June 2014

Concurrent Technologies Plc (the "Company"), a world leading specialist in the design and manufacture of high-end embedded computer products, for critical applications in the defence, aerospace, transportation, telecommunications, scientific and industrial markets, announces interim results for the six months to 30 June 2014.

Highlights:

· Turnover £5.6m (H1 2013: £5.3m)

· Profit before tax £0.4m (H1 2013: £0.4m)

· Earnings per share for the period 0.56p (H1 2013: 0.66p)

· Interim dividend 0.65p per share (H1 2013: 0.65p)

· Net cash, including cash deposits £4.8m (H1 2013: £5.3m); no borrowings

Operational Highlights:

· Release of four new products

· Increased investment in R&D and creation of engineering facility in the USA

· Investment in new X-ray equipment for manufacturing

Michael Collins, Chairman, commented:

"Our order book is good and our cash position remains strong. With the introduction by the UK Government of the more flexible licensing system, we can now focus on restoring customer confidence in those areas affected. How long it will take to recover from the effects of UK export licensing regulations, and what their full impact might be, remains difficult to assess at this time, but the Board is confident that the resolution of the major export licensing issues, together with the diversity of the Company's product range and customer base, will generate sound results."

 

Enquiries:

 

Concurrent Technologies PlcGlen Fawcett, Managing Director

 

+44 (0)1206 752 626

Newgate Threadneedle (Financial PR)Caroline Forde

Robyn McConnachie

+44 (0)207 653 9850

Cenkos Securities plc (NOMAD)Neil McDonald

Beth McKiernan

+44 (0)131 220 9771+44 (0)131 220 9778

 

CHAIRMAN'S STATEMENT

 

Financial Summary

 

Given the backdrop of continuing export licence problems for customers in many markets, I am pleased to report a satisfactory start to 2014. The Group achieved a profit before tax for the six months to 30 June 2014 of £424,338 (H1 2013: £370,528) with associated earnings per share of 0.56 pence (H1 2013: 0.66 pence). Turnover for the period was £5,574,557 (H1 2013: £5,319,772), with a significant increase in sales into telecommunications applications. Our cash balances (including cash deposits) at 30 June 2014 remain healthy at £4,846,837 (H1 2013: £5,331,742) even after paying an increased dividend after the year end, and continued investment in R&D at a slightly increased level compared to the first half of 2013.

 

Review of Operations

 

Turnover during the first half of 2014 was in line with expectations although exports have fallen to 54% of turnover (H1 2013: 72%) which was expected due to the application of UK Government export control regulations to our advanced technology products incorporating encryption technology. As a consequence of these export controls, the Board has determined that a further write down in the value of certain designs may be required; the exact amount will be finalised at the year end and incorporated into the results for the full year ending 31 December 2014.

 

Throughout the second half of 2013 and the first half of 2014, the Company has been working closely with BIS (Department for Business, Innovation and Skills) which has been reviewing the current system of controls. In mid-July 2014, we were notified that BIS had published a generally applicable export licence that substantially decontrols the exporting of encryption products of the type that the Company produces. This licence will considerably simplify the exporting of affected products to key markets outside of the EU and USA.

 

We have continued to invest in the development of our expanding product ranges and we have released four new products during the first half of this financial year. Two of these are based on the AMC architecture and a further two feature the Intel® Atom™ processor. The latter products are low power computers specifically targeted to offer excellent performance per Watt and are based on the VME and CompactPCI® bus architectures. These single board computers are suitable for applications in our usual markets and support a range of industry standard operating systems.

 

The Group has implemented its plan to establish an engineering facility in Massachusetts, USA, and US engineers are already augmenting the UK and Indian engineering teams.

 

We have also invested in new X-ray equipment in our manufacturing facility, which is able to perform 3D scanning and make sectional images. This has substantially improved our ability to see inside ever smaller and more complex components and parts of our products to identify faults and ensure the highest quality of manufacture.

 

The executive directors exercised their share options 8th April 2014, resulting in an issue of 1.2m shares and an inflow of £300,000 cash.

 

Future Plans

 

Our strategy is to continue to expand our range by developing products for the VPX™, VME, AMC and CompactPCI® bus architectures in complex, high technology, low to medium volume and high margin applications. Many versions of these products will be designed for use in harsh environments. The continuing development of new and complementary software packages to provide high-speed data transfer, ease of integration and security will further enhance our product portfolio. We will also continue to recruit in the USA to build up our engineering team there.

 

Dividend

 

The Board has declared a first interim dividend that will be maintained at the same level as that for last year, namely, 0.65p per share (H1 2013: 0.65p). The total cost of this dividend will amount to £471,903. The ex-dividend date for the interim dividend is 10 September 2014, the record date is 12 September 2014 and the payment date is 26 September 2014.

 

Outlook

 

Our order book is good and our cash position remains strong. With the introduction by the UK Government of the more flexible licensing system, we can now focus on restoring customer confidence in those areas affected. How long it will take to recover from the effects of UK export licensing regulations, and what their full impact might be, remains difficult to assess at this time, but the Board is confident that the resolution of the major export licensing issues, together with the diversity of the Company's product range and customer base, will generate sound results.

 

Michael Collins

Chairman

 

22 August 2014

 

All companies and product names are trademarks of their respective organisations.

 

 

CONDENSED CONSOLIDATED STATEMENT OF

COMPREHENSIVE INCOME

unaudited interim results to 30 June 2014

 

Note

Six months ended

30/06/14

Six months ended

30/06/13

Year ended 31/12/13

£

£

£

CONTINUING OPERATIONS

Revenue

5,574,557

5,319,772

11,859,180

Cost of sales

2,899,117

2,611,202

5,857,094

Gross profit

2,675,440

2,708,570

6,002,086

Net operating expenses

2,286,611

2,369,420

5,614,290

Group operating profit

388,829

339,150

387,796

Finance income

35,509

31,378

66,133

Profit before tax

424,338

370,528

453,929

Tax

24,923

(102,822)

(275,688)

Profit for the period

399,415

473,350

729,617

Other Comprehensive Income

Exchange differences on translating foreign operations

(29,037)

127,433

(124,637)

Tax relating to components of other comprehensive income

-

-

-

Other Comprehensive Income for the period, net of tax

(29,037)

127,433

(124,637)

Total Comprehensive Income for the period

370,378

600,783

604,980

Profit for the period attributable to:

Equity holders of the parent

399,415

473,350

729,617

Total Comprehensive Income attributable to:

Equity holders of the parent

370,378

600,783

604,980

Earnings per share

Basic earnings per share

4

0.56p

0.66p

1.02p

Diluted earnings per share

4

0.55p

0.66p

1.01p

 

 

CONDENSED CONSOLIDATED BALANCE SHEET

unaudited interim results to 30 June 2014

 

As at

As at

As at

30/06/14

30/06/13

31/12/13

ASSETS

£

£

£

Non-current assets

Property, plant and equipment

609,986

393,125

478,131

Intangible assets

5,845,981

6,262,359

5,467,503

Deferred tax assets

82,813

190,303

108,396

Other financial assets

-

1,000,000

-

6,538,780

7,845,787

6,054,030

Current assets

Inventories

2,536,345

2,828,830

2,550,556

Trade and other receivables

2,210,893

2,092,746

2,874,354

Current tax assets

284,726

186,933

247,240

Other financial assets

2,585,066

1,000,000

2,602,689

Cash and cash equivalents

2,261,771

3,331,742

2,340,859

9,878,801

9,440,251

10,615,698

Total assets

16,417,581

17,286,038

16,669,728

LIABILITIES

Non-current liabilities

Deferred tax liabilities

1,257,824

1,315,342

1,164,267

Long term provisions

10,009

-

10,009

1,267,833

1,315,342

1,174,276

Current liabilities

Trade and other payables

1,708,720

1,751,526

1,931,110

Short term provisions

36,813

39,746

36,813

Current tax liabilities

2,998

26,196

-

1,748,531

1,817,468

1,967,923

Total liabilities

3,016,364

3,132,810

3,142,199

Net assets

13,401,217

14,153,228

13,527,529

EQUITY

Capital and reserves

Share capital

 739,000

 727,000

727,000

Share premium account

3,693,818

3,405,817

3,405,817

Capital redemption reserve

 256,976

 256,976

256,976

Cumulative translation reserve

(103,853)

177,254

(74,816)

Profit and loss account

8,815,276

9,586,181

9,212,552

Equity attributable to equity holders of the parent

13,401,217

14,153,228

13,527,529

Total equity

13,401,217

14,153,228

13,527,529

 

 

CONDENSED CONSOLIDATED CASH FLOW STATEMENT

unaudited interim results to 30 June 2014

 

Six months ended

30/06/14

Six months ended

30/06/13

 

Year ended 31/12/13

£

£

£

Cash flows from operating activities

Profit before tax for the period

424,338

370,528

453,929

Adjustments for:

Finance income

(35,509)

(31,378)

(66,133)

Depreciation

85,070

84,320

169,259

Amortisation

588,056

687,446

1,363,530

Impairment loss

-

-

842,783

Loss on disposal of property, plant and equipment

-

-

-

Share-based payment

2,814

5,553

(94,726)

Exchange differences

15,635

69,188

(74,551)

(Increase)/decrease in inventories

14,211

138,860

417,134

(Increase)/decrease in trade and other receivables

663,461

1,181,919

400,311

Increase/(decrease) in trade and other payables

(222,390)

239,771

426,431

Cash generated from operations

1,535,685

2,746,207

3,837,967

Tax received/(paid)

45,628

(30,154)

(61,654)

Net cash generated from operating activities

1,581,313

2,716,053

3,776,313

Cash flows from investing activities

Interest received

35,509

31,378

66,133

Cash placed on deposit

-

-

(602,689)

Purchases of property, plant and equipment

(217,066)

(40,676)

(225,505)

Purchases of intangible assets

(966,532)

(1,001,051)

(1,726,312)

Net cash used in investing activities

(1,148,088)

(1,010,349)

(2,488,373)

Cash flows from financing activities

Equity dividends paid

(785,404)

(750,123)

(1,214,420)

Cash received from share issue

300,000

-

-

Purchase of treasury shares

-

-

(16,625)

Net cash used in financing activities

(485,404)

(750,123)

(1,231,045)

Effects of exchange rate changes on cash and cash equivalents

(26,909)

59,233

(32,964)

Net increase/(decrease) in cash

(79,088)

1,014,814

23,931

Cash at beginning of period

2,340,859

2,316,928

2,316,928

Cash at the end of the period

2,261,771

3,331,742

2,340,859

 

 

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

unaudited interim results to 30 June 2014

 

Share

capital

Share

Premium

Capital

redemption

reserve

Cumulative

translation

reserve

Profit

and loss

account

Total

equity

 

£

£

£

£

£

£

 

 

 

 

Balance at 1 January 2013

727,000

3,405,817

256,976

49,821

9,862,012

14,301,626

Profit for the period

-

-

-

-

473,350

473,350

Exchange differences on translating foreign operations

-

-

-

127,433

-

127,433

Total recognised comprehensive income for the period

-

-

-

127,433

473,350

600,783

Share-based payment

-

-

-

-

5,553

5,553

Deferred tax on share based payment

-

-

-

-

(4,611)

(4,611)

Dividends paid

-

-

-

-

(750,123)

(750,123)

Sale of treasury shares

-

-

-

-

-

-

Balance at 30 June 2013

727,000

3,405,817

256,976

177,254

9,586,181

14,153,228

Profit for the period

-

-

-

-

256,267

256,267

Exchange differences on translating foreign operations

-

-

-

(252,070)

-

(252,070)

Total recognised comprehensive income for the period

-

-

-

(252,070)

256,267

4,197

Share-based payment

-

-

-

-

(100,279)

(100,279)

Deferred tax on share based payment

-

-

-

-

(48,695)

(48,695)

Dividends paid

-

-

-

-

(464,297)

(464,297)

Purchase of treasury shares

-

-

-

-

(16,625)

(16,625)

Balance at 31 December 2013

727,000

3,405,817

256,976

(74,816)

9,212,552

13,527,529

Profit for the period

-

-

-

-

399,415

399,415

Exchange differences on translating foreign operations

-

-

-

(29,037)

-

(29,037)

Total recognised comprehensive income for the period

-

-

-

(29,037)

399,415

370,378

Share-based payment

-

-

-

-

2,814

2,814

Deferred tax on share based payment

-

-

-

-

(14,101)

(14,101)

Dividends paid

-

-

-

-

(785,404)

(785,404)

Issue of ordinary shares

12,000

288,001

-

-

-

300,001

Purchase of treasury shares

-

-

-

-

-

-

Balance at 30 June 2014

739,000

3,693,818

256,976

(103,853)

8,815,276

13,401,217

 

 

NOTES TO THE INTERIM REPORT

 

1.

General information

 

The principal activity of Concurrent Technologies Plc and its subsidiaries ("the Group") is the design, development, manufacture and marketing of single board computers for system integrators and original equipment manufacturers.

 

Concurrent Technologies Plc ("the Company") is the Group's ultimate parent company. It is incorporated and domiciled in Great Britain. Concurrent Technologies Plc shares are listed on the Alternative Investment Market of the London Stock Exchange.

 

The Group's condensed consolidated interim financial statements are presented in pounds sterling (£), which is also the functional currency of the parent company.

 

These condensed consolidated interim financial statements, which are unaudited, have been approved for issue by the Board of Directors on 26 August 2014.

 

The information relating to the six months ended 30 June 2014 and 30 June 2013 is unaudited and does not constitute statutory accounts within the meaning of section 435 of the Companies Act 2006. The statutory accounts for the year ended 31 December 2013, prepared under adopted IFRS (International Financial Reporting Standards), have been reported on by the Group's auditors and delivered to the Registrar of Companies. The auditors' report in accordance with Chapter 3 of Part 16 of the Companies Act 2006 in relation to those accounts was unqualified.

 

2.

Summary of significant accounting policies

 

2.1

Basis of preparation

 

These condensed consolidated interim financial statements are for the six months ended 30 June 2014. They have been prepared in accordance with IAS 34 "Interim Financial Reporting". They do not include all of the information required for full annual financial statements, and should be read in conjunction with the consolidated financial statements of the Group for the year ended 31 December 2013, which have been prepared in accordance with IFRSs.

 

The accounting policies applied and methods of computation are consistent with those of the annual financial statements for the year ended 31 December 2013, as described in those financial statements. The accounting policies have been consistently applied to all the periods presented.

 

There are no new IFRSs or IFRIC interpretations that are effective for the first time for the financial period beginning on or after 1 January 2014 that would be expected to have a material impact on the results or financial position of the Group.

 

2.2

Taxation

 

Current tax expense is recognised in these condensed consolidated interim financial statements based on estimated effective tax rates for the full year.

 

3.

Segmental reporting

 

The Directors consider that the Group is engaged in a single segment of business, being design, manufacture and supply of high-end embedded computer products, and that therefore the Company has only a single operating segment. The key measure of performance used by the Board to assess the Group's performance is the Group's profit before tax, as calculated under IFRS, and therefore no reconciliation is required between the measure of profit or loss used by the Board and that contained in the condensed consolidated interim financial statements.

 

4.

Earnings per share

 

Basic earnings per share is calculated by dividing the profit attributable to ordinary equity holders for the period by the weighted average number of ordinary shares outstanding during the period.

 

Diluted earnings per share is calculated adjusting the weighted average number of ordinary shares outstanding to assume conversion of all contracted dilutive potential ordinary shares. The Company only has one category of dilutive potential ordinary shares, share options.

 

The inputs to the earnings per share calculation are shown below:

 

 

 

Six months ended

30/06/14

Six months ended

30/06/13

Year ended 31/12/13

£

£

£

Profit attributable to ordinary equity holders

399,415

473,350

729,617

Six months ended

30/06/14

Six months ended

30/06/13

Year ended 31/12/13

No

No

No

Weighted average number of ordinary

shares for basic earnings per share

71,950,766

71,440,490

71,430,298

Adjustment for share options

22,337

653,499

593,207

Weighted average number of ordinary shares for diluted earnings per share

71,973,103

72,093,989

72,023,505

5.

Copies of this report will be sent to shareholders and are available at the Company's Registered Office.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR LIFFTTDIVFIS
Date   Source Headline
1st May 20247:00 amRNSFinal results for the year ended 31 December 2023
24th Apr 20247:00 amRNSUS Contract Win and Notice of Results
9th Apr 20247:00 amRNSNew Product Announcement
5th Feb 20247:00 amRNSBoard Appointment
17th Jan 20247:00 amRNSTrading update
21st Dec 20237:00 amRNSKey VME Contract Win
19th Dec 20231:07 pmRNSHolding(s) in Company
27th Nov 20237:00 amRNSTrading Update
9th Nov 20237:00 amRNSNew Product Announcement
8th Nov 20237:00 amRNSChange of Nominated Adviser
7th Nov 20237:00 amRNSAppointment of New Auditors
2nd Nov 20237:00 amRNSHolding(s) in Company
24th Oct 20237:00 amRNSDirector/PDMR Dealing - Issue of Share Options
28th Sep 20237:00 amRNSNew Product Announcement
19th Sep 20237:00 amRNSInterim Results
6th Sep 20237:00 amRNSAcquisition of Phillips Aerospace
5th Sep 202312:04 pmRNSHolding(s) in Company
5th Sep 20237:00 amRNSNotice of Results
4th Sep 20231:20 pmRNSResult of General Meeting
25th Aug 20237:00 amRNSResult of Retail Offer
24th Aug 20233:07 pmRNSResult of AGM
16th Aug 20237:05 amRNSRetail Offer for up to £0.3 million
16th Aug 20237:00 amRNSProposed Acquisition and Notice of General Meeting
11th Aug 20233:15 pmRNSHolding(s) in Company
8th Aug 20237:00 amRNSNew Product Announcement
1st Aug 202310:58 amRNSNew Product Announcement
20th Jul 20237:00 amRNSNotification of Major Holdings
18th Jul 20237:00 amRNSPosting of Annual Report and Notice of AGM
17th Jul 20237:00 amRNSPost-Close Trading Update
30th Jun 20237:00 amRNSResults for the year ended 31 December 2022
19th Jun 20237:00 amRNSUpdate on Audited Annual Results
12th Jun 20237:00 amRNSSignificant Systems Win
9th Jun 20235:11 pmRNSNotification of Major Holdings
7th Jun 20237:00 amRNSNew Distributor Agreement
5th Jun 20237:00 amRNSNotice of Results
24th Mar 20237:00 amRNSNew Product Announcement
21st Mar 20237:00 amRNSReseller Agreement
4th Jan 20237:00 amRNSPost-Close Trading Update
14th Dec 20227:00 amRNSPartnership Agreement
28th Oct 20227:00 amRNSIssue of Share options and PDMR dealing
5th Oct 20227:00 amRNSConcurrent Technologies Enters the Systems Market
26th Sep 20227:00 amRNSInterim Results
12th Sep 20227:00 amRNSNotice of Interim Results
24th Aug 202210:29 amRNSHolding(s) in Company
24th Aug 202210:27 amRNSHolding(s) in Company
19th Aug 202212:06 pmRNSHolding(s) in Company
13th Jul 20227:00 amRNSSupply Agreement
29th Jun 202212:55 pmRNSResult of AGM
30th May 20227:00 amRNSPosting of Annual Report & Notice of AGM
23rd May 20222:46 pmRNSIssue of Share options and PDMR dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.